Peter Zerhouni CFO and CBO Affibody

Tue, Oct 03, 2023 10:14 CET

Medium resolution

Original resolution

Subscribe

Related Releases

First gastroesophageal cancer patients enrolled in Phase 2 basket trial using Affibody’s PET imaging agent ABY-025 Tue, Mar 26, 2024 09:14 CET